1. Strom B, Kimmel S. Textbook of Pharmacoepidemiology. Hoboken, NJ: Wiley; 2006.
2. Miller, JL. Troglitazone withdrawn from market. Am J Health Syst Pharm. May 1, 2000; 57(9):834.
3. Gale EA. Lessons from the glitazones: a story of drug development. Lancet. June 9, 2001; 357(9271):1870–1875.
4. Scheen AJ. Thiazolidinediones and liver toxicity. Diabetes Metab. June 2001; 27(3):305–313.
5. Glessner MR, Heller DA. Changes in related drug class utilization after market withdrawal of cisapride. Am J Manag Care. Mar 2002; 8(3):243–250.